Delisting risk
BullFrog AI (BFRG)
Applies AI-driven biomedical data analysis to drug development.
$0.4800
Pre-market−0.02 (−3.94%)
At close$0.4997(+2.78%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions21 holders · as of Jun 30, 2026 | 6.36% | 1.18M shares | |
| Insiders5 holders · as of Aug 26, 2025 | 13.01% | 2.41M shares | |
| Otherremainder | 80.63% | 14.95M shares |
18.54M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Institutions13F, as of Jun 30, 2026
21 holders · 1.18M shares · 9 new positions · 16 increased · 1 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Citadel Advisors LLC | 361.5K | 1.95% | +361.5K | Aug 14, 2026 |
| J. Safra Sarasin Holding AG | 113.7K | 0.61% | 0 | Jul 31, 2026 |
| Vanguard Fiduciary Trust Co | 106.5K | 0.57% | +80.9K | Aug 13, 2026 |
| Geode Capital Management, LLC | 104.9K | 0.57% | +25.1K | Aug 12, 2026 |
| Vanguard Capital Management LLC | 91.6K | 0.49% | +25.0K | Aug 13, 2026 |
| Vontobel Holding Ltd. | 70.0K | 0.38% | +32.0K | Aug 3, 2026 |
| Jane Street Group, LLC | 66.0K | 0.36% | +66.0Knew | Aug 14, 2026 |
| Act Advisors, LLC. | 56.4K | 0.30% | +56.4Knew | Jul 22, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.